REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
The New England journal of medicine · 2021 · 1,331 citations · Cynthia Pan
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.
Heart rhythm · 2023 · 442 citations · David Slotwiner
Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review.
Journal of the American College of Cardiology · 2022 · 354 citations · Archana Bushan
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.
Journal of the American College of Cardiology · 2021 · 420 citations · Anderly Cordero
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
The New England journal of medicine · 2021 · 526 citations · Cynthia Pan
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.
Lancet (London, England) · 2022 · 255 citations · Zsolt Kulcsar
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
JAMA internal medicine · 2021 · 372 citations · Janice Wang
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study.
JACC. Heart failure · 2021 · 228 citations · Anderly Cordero